Ocular Hypertension
📧 Sign up to get email alerts when something new happens for Ocular Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-05-20FDA Approved: TIMOLOL MALEATE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for timolol maleate from Rising Pharma Holdings, Inc., authorizing changes to an existing generic pr…
-
FDA approval · 2025-05-16FDA Approved: TIMOLOL MALEATE — Supplemental Application (First Nation Group, LLC)
The FDA approved a supplemental application for TIMOLOL MALEATE from First Nation Group, LLC, authorizing a new generic product on the marke…
-
FDA approval · 2025-05-08FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Supplemental Application (Sagent Pharmaceuticals)
FDA approved a supplemental application for dorzolamide hydrochloride from Sagent Pharmaceuticals, authorizing this generic drug for lowerin…
-
FDA approval · 2025-04-29FDA Approved: LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION, 0.024% — Original Application (Gland Pharma Limited)
The FDA approved a generic latanoprostene bunod ophthalmic solution, 0.024%, from Gland Pharma Limited under an Original Application. It is …
-
FDA approval · 2025-04-28FDA Approved: PILOCARPINE HYDROCHLORIDE OPHTHALMIC — Original Application (Amneal Pharmaceuticals NY LLC)
The FDA approved the original application for Pilocarpine Hydrochloride Ophthalmic from Amneal Pharmaceuticals NY LLC, providing a generic p…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-04-25FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Supplemental Application (Gland Pharma Limited)
FDA approved a supplemental application for a generic dorzolamide hydrochloride and timolol maleate eye drop from Gland Pharma Limited. The …
-
FDA approval · 2025-04-14FDA Approved: LATANOPROST — Original Application (Micro Labs Limited)
FDA approved latanoprost from Micro Labs Limited through an original application; indicated to reduce intraocular pressure in open-angle gla…
-
FDA approval · 2025-03-27FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE OPHTHALMIC SOLUTION — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application from Micro Labs Limited for dorzolamide hydrochloride and timolol maleate ophthalmic solution. This …
-
FDA approval · 2025-03-17FDA Approved: BIMATOPROST — Original Application (Lifestar Pharma LLC)
FDA approved the original application for Bimatoprost by Lifestar Pharma LLC, granting approval for a generic ophthalmic solution intended t…
-
FDA approval · 2025-02-25FDA Approved: BRIMONIDINE TARTRATE/TIMOLOL MALEATE OPHTHALMIC SOLUTION — Original Application (Leading Pharma, LLC)
FDA approved a generic fixed-dose combination ophthalmic solution of brimonidine tartrate and timolol maleate from Leading Pharma, LLC under…
-
FDA approval · 2025-02-18FDA Approved: DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE — Original Application (Genus Lifesciences)
FDA approved the original application for a generic dorzolamide hydrochloride and timolol maleate combination to treat elevated intraocular …
-
FDA approval · 2025-02-11FDA Approved: DORZOLAMIDE HYDROCHLORIDE — Original Application (Somerset Therapeutics, LLC)
FDA approved a generic dorzolamide hydrochloride product under an Original Application by Somerset Therapeutics, LLC. Dorzolamide hydrochlor…
-
EMA approval · 2025-01-27EMA Authorised: Izba (travoprost) — Novartis Europharm Limited
The European Medicines Agency authorised Izba, a travoprost eye drop by Novartis Europharm Limited, for ocular hypertension and open-angle g…
-
FDA approval · 2025-01-24FDA Approved: ROCKLATAN — Supplemental Application (Alcon Laboratories, Inc.)
FDA approved a supplemental application for ROCKLATAN (netarsudil and latanoprost ophthalmic solution) from Alcon Laboratories, Inc.
-
FDA approval · 2024-11-26FDA Approved: LATANOPROST — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for latanoprost from Sagent Pharmaceuticals (a generic).
-
EMA approval · 2024-11-18EMA Authorised: Ganfort (bimatoprost;timolol) — AbbVie Deutschland GmbH & Co. KG
The European Medicines Agency authorised Ganfort, a combination of bimatoprost and timolol, for glaucoma (open-angle) and ocular hypertensio…
-
EMA approval · 2024-11-18EMA Authorised: Lumigan (bimatoprost) — AbbVie Deutschland GmbH & Co. KG
The EMA authorised Lumigan (bimatoprost) for open-angle glaucoma and ocular hypertension, with AbbVie Deutschland GmbH & Co. KG as the marke…
-
FDA approval · 2024-10-10FDA Approved: DURYSTA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Durysta (bimatoprost) from Allergan, Inc., to modify the product’s labeling and/or approved …
-
FDA approval · 2024-10-10FDA Approved: TIMOLOL HEMIHYDRATE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for Timolol hemihydrate, a generic ophthalmic solution, from Somerset Therapeutics, LLC.
-
FDA approval · 2024-10-09FDA Approved: XELPROS — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for XELPROS (latanoprost) submitted by Sun Pharmaceutical Industries.
-
FDA approval · 2024-09-23FDA Approved: TRAVOPROST — Original Application (Somerset Therapeutics, LLC)
FDA approved an Original Application for Travoprost from Somerset Therapeutics, LLC (ANDA 217228), indicating approval of a generic Travopro…
-
FDA approval · 2024-09-18FDA Approved: RHOPRESSA — Supplemental Application (Alcon Laboratories, Inc.)
FDA approves a supplemental application for RHOPRESSA (netarsudil) filed by Alcon Laboratories, Inc.
-
FDA approval · 2024-09-16FDA Approved: IYUZEH — Supplemental Application (Thea Pharma Inc.)
FDA approves a supplemental application for IYUZEH (latanoprost ophthalmic solution 0.005%). This approval expands the product's labeling re…
-
FDA approval · 2024-09-16FDA Approved: TIMOLOL MALEATE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for TIMOLOL MALEATE (generic) by Somerset Therapeutics, LLC, for ophthalmic use to treat elevated intr…
-
FDA approval · 2024-09-10FDA Approved: BRIMONIDINE TARTRATE AND TIMOLOL MALEATE — Original Application (Somerset Therapeutics, LLC)
FDA approved a new original application for a fixed-dose combination eye drop of brimonidine tartrate and timolol maleate for lowering intra…